Educational purposes only. Not investment advice. Past performance does not guarantee future results. View full terms

RGNX

REGENXBIO Inc. β€’ Healthcare (#5 of 11)

$8.63
+0.25 (+2.98%)
View:
Close:$8.63
Vol:LOW(0%ile)
Ratio:0.60x
|
RSI:49(Neutral)
MACD:↑
β‰₯75%25-75%<25%
Vol.%
Sector Rotation
2026-04-01(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRAL
β–²0 Upβ–Ό0 Down2 Hold
Mar 9HC Wainwright & Co.
–Buy
Mar 6Morgan Stanley
–Overweight
Price Targets
(60d mean: $27, +215.8%)
NEUTRAL
β–²0 Raisesβ–Ό2 Lowers
Mar 9HC Wainwright & Co.
$32β†’$30-6.3%
Mar 6Morgan Stanley
$18β†’$17-5.6%
Trade Setup
Entry$8.63
Target$9.95 (+15.3%)
Stop$7.31
R/R1.00
Risk-15.3%
Conv27 (LOW)
Size335 shares ($2,891)
Risk Metrics
Sharpe (20d)
-0.26Losing
Volatility (20d)
101.8%Extreme
Beta (60d)
2.32Aggressive
Alpha (20d)
-1.3%In Line
News Analysis
EN
δΈ­
ν•œ
ζ—₯

No analysis record found.